Literature DB >> 27330787

Differences in displacement of the proximal and distal ends of mid-upper thoracic esophageal squamous cell carcinoma.

Guoqin Qiu1, Dengshun Wen1, Xianghui DU1, Liming Sheng1, Xia Zhou1, Yongling Ji1, Wuan Bao1, Danhong Zhang1, Lei Cheng1.   

Abstract

In the present study, clips were used as markers to evaluate displacement differences between proximal and distal ends of esophageal tumors and to test whether their internal target volume (ITV) margins should be determined separately. A total of 23 patients with mid-upper thoracic esophageal squamous-cell carcinoma, a tumor length of ≤8 cm and an esophageal lumen suitable for endoscopic ultrasonography were recruited for the present study. Clips were implanted endoscopically at the proximal and distal ends of the esophageal tumor (upper and lower clips). In a further exploratory study on 16 of the patients, a third clip was placed at the distal esophagus 2 cm above the gastro-esophageal junction (GEJ) (cardiac clip). The clips were contoured for all 10 phases of the four-dimensional computed tomography and the maximum displacements of the clip centroids among different breathing phases in left-right (LR), superior-inferior (SI) and anterior-posterior (AP) directions were marked as x, y and z, respectively. The ITV margins that covered 95% of the LR, SI and AP motion were 2.89, 5.00 and 2.36 mm, respectively. Axial displacement (y) was greater than radial displacement (x, z; P<0.05). It was also revealed that LR(x), SI(y) and AP(z) displacement of cardiac clips was greater than that of upper or lower clips (P<0.05). Differences in the axial and radial displacement of the upper and lower clips indicated that axial and radial ITV margins should be determined separately. However, further study is required on patients in whom the distal tumor end is located in proximity to the GEJ.

Entities:  

Keywords:  clip; esophageal cancer; four-dimensional computed tomography; internal target volume

Year:  2016        PMID: 27330787      PMCID: PMC4907031          DOI: 10.3892/mco.2016.899

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  16 in total

1.  Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors.

Authors:  Takayuki Hashimoto; Hiroki Shirato; Mototsugu Kato; Koichi Yamazaki; Nobuaki Kurauchi; Toshiaki Morikawa; Shinichi Shimizu; Yong Chan Ahn; Yasuyuki Akine; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

2.  Intra- and interfractional variations in geometric arrangement between lung tumours and implanted markers.

Authors:  Nami Ueki; Yukinori Matsuo; Mitsuhiro Nakamura; Nobutaka Mukumoto; Yusuke Iizuka; Yuki Miyabe; Akira Sawada; Takashi Mizowaki; Masaki Kokubo; Masahiro Hiraoka
Journal:  Radiother Oncol       Date:  2014-02-20       Impact factor: 6.280

3.  Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer.

Authors:  Hideomi Yamashita; Satoshi Kida; Akira Sakumi; Akihiro Haga; Saori Ito; Tsuyoshi Onoe; Kae Okuma; Kenji Ino; Masaaki Akahane; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-01       Impact factor: 7.038

4.  Four-dimensional measurement of the displacement of internal fiducial and skin markers during 320-multislice computed tomography scanning of breast cancer.

Authors:  Hideomi Yamashita; Kae Okuma; Keiichiro Tada; Kenshiro Shiraishi; Wataru Takahashi; Shino Shibata-Mobayashi; Akira Sakumi; Naoya Saotome; Akihiro Haga; Tsuyoshi Onoe; Kenji Ino; Masaaki Akahane; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-19       Impact factor: 7.038

5.  Esophageal cancer: determination of internal target volume for conformal radiotherapy.

Authors:  F Lorchel; J L Dumas; A Noël; D Wolf; J F Bosset; P Aletti
Journal:  Radiother Oncol       Date:  2006-09-07       Impact factor: 6.280

6.  Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.

Authors:  Kuai-le Zhao; Zhongxing Liao; M Kara Bucci; Ritsuko Komaki; James D Cox; Zhiqian H Yu; Lifei Zhang; Radhe Mohan; Lei Dong
Journal:  Radiother Oncol       Date:  2007-08-22       Impact factor: 6.280

7.  The value of endoscopic ultrasonography in defining longitudinal gross target volumes for esophageal squamous carcinoma.

Authors:  Guo-qin Qiu; Xiang-hui Du; Jiang-ping Yu; Yuan-da Zheng; Hao-Jie Luo; Ya-ping Xu; Jian-xiang Chen; Xiao-Jiang Sun; Yong-ling Ji; Ya-li Tao
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-10       Impact factor: 1.719

8.  Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.

Authors:  Marjan A Admiraal; Danny Schuring; Coen W Hurkmans
Journal:  Radiother Oncol       Date:  2007-12-20       Impact factor: 6.280

9.  Using four-dimensional computed tomography images to optimize the internal target volume when using volume-modulated arc therapy to treat moving targets.

Authors:  Nikolaos Yakoumakis; Brian Winey; Joseph Killoran; Charles Mayo; Thomas Niedermayr; George Panayiotakis; Tania Lingos; Laurence Court
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

10.  A comparative study on the volume and localization of the internal gross target volume defined using the seroma and surgical clips based on 4DCT scan for external-beam partial breast irradiation after breast conserving surgery.

Authors:  Yun Ding; Jianbin Li; Wei Wang; Suzhen Wang; Jinzhi Wang; Zhifang Ma; Qian Shao; Min Xu
Journal:  Radiat Oncol       Date:  2014-03-19       Impact factor: 3.481

View more
  1 in total

1.  Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3.

Authors:  Yuta Kobayashi; Miyako Myojin; Shinichi Shimizu; Masao Hosokawa
Journal:  Adv Radiat Oncol       Date:  2016-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.